Correction to: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD (Nature Medicine, (2024), 30, 2, (382-393), 10.1038/s41591-023-02788-5)

Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, Irika R. Sinha, Mark A. Garret, Kyra D. Bowden, Koping Chang, Juan C. Troncoso, Abhay Moghekar, Esther S. Oh, Denitza Raitcheva, Dan Bartlett, Timothy Miller, James D. Berry, Bryan J. Traynor, Jonathan P. Ling, Philip C. Wong

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02788-5, published online 26 January 2024. In the version of the article initially published, in the “Analysis with reverse transcription PCR” section of the Methods, the HDG F primer originally read 5′-CTCGGAGGCTTCTTCACAGAC-3′ and has now been corrected to 5′-AAGACGCCTGCGCTAAAGAT-3′ in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)1504
Number of pages1
JournalNature medicine
Volume30
Issue number5
DOIs
StatePublished - May 2024

Fingerprint

Dive into the research topics of 'Correction to: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD (Nature Medicine, (2024), 30, 2, (382-393), 10.1038/s41591-023-02788-5)'. Together they form a unique fingerprint.

Cite this